1. Home
  2. List
Reference Patent

Reference - List

  • 8 Hits
  • Search Condition : Filter (MeSH = Piperazines / administration & dosage)
Species Resource Title
Human and Animal Cells WEHI-3(RCB0035) , Ba/F3(RCB0805) Synergistic killing effect of imatinib and simvastatin on imatinib-resistant chronic myelogenous leukemia cells.
Human and Animal Cells JHOC-5(RCB1520) Inhibition of the MYC-Regulated Glutaminase Metabolic Axis Is an Effective Synthetic Lethal Approach for Treating Chemoresistant Ovarian Cancers.
Human and Animal Cells HSC-2(RCB1945) , Ca9-22(RCB1976) , SAS(RCB1974) Synergetic Effects of PARP Inhibitor AZD2281 and Cisplatin in Oral Squamous Cell Carcinoma in Vitro and in Vivo.
Human and Animal Cells HSC-4(RCB1902) , SAS(RCB1974) , Ca9-22(RCB1976) Migration of oral squamous cell carcinoma cells are induced by HGF/c-Met signalling via lamellipodia and filopodia formation.
Human and Animal Cells HCT116(RCB2979) H3B-8800, an orally available small-molecule splicing modulator, induces lethality in spliceosome-mutant cancers.
Human and Animal Cells HGC-27(RCB0500) Autophagy Induced by Naftopidil Inhibits Apoptosis of Human Gastric Cancer Cells.
Human and Animal Cells KU812(RCB0495) , K562 Sorafenib induces apoptosis specifically in cells expressing BCR/ABL by inhibiting its kinase activity to activate the intrinsic mitochondrial pathway.
Human and Animal Cells K562(RCB0027) Depsipeptide enhances imatinib mesylate-induced apoptosis of Bcr-Abl-positive cells and ectopic expression of cyclin D1, c-Myc or active MEK abrogates this effect.